Anagenics Ltd has released a press release.
Rights Issue Prospectus
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Rights Issue
- Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer
- Cellmid Receives First Order From Chinese Distributor
- Cellmid Signs 10 Year Chinese Distribution Agreement
- Growth Strategy Presentation
Later from Anagenics
- Rights Issue Closed with Strong Demand
- Supplementary Prospectus
- Agreement Signed for Sale of Lyramid Limited
- Chinese Import Permits Received
- Supply Agreement for Cellmids FGF5 Inhibitors
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics